vs
Fair Isaac(FICO)とSelectQuote, Inc.(SLQT)の財務データ比較。上の社名をクリックして会社を切り替えられます
SelectQuote, Inc.の直近四半期売上が大きい($537.1M vs $512.0M、Fair Isaacの約1.0倍)。Fair Isaacの純利益率が高く(30.9% vs 12.9%、差は18.0%)。Fair Isaacの前年同期比売上増加率が高い(16.4% vs 11.6%)。Fair Isaacの直近四半期フリーキャッシュフローが多い($173.9M vs $-1.0M)。過去8四半期でSelectQuote, Inc.の売上複合成長率が高い(19.5% vs 8.6%)
FICO(旧社名Fair, Isaac and Company)は米国モンタナ州ボーズマンに本社を置くデータ分析企業で、1956年にビル・フェアとアール・アイザックにより創業されました。消費者の信用リスクを測定するFICOスコアは、米国の消費者融資業界で広く活用されています。
SelectQuoteは消費者向け直接販売プラットフォームで、保険契約と医療サービスを提供しています。消費者と保険会社を結びつけることで手数料を得て、シニア健康保険、生命保険、自動車保険、住宅保険を扱っています。医療サービスは認定薬局SelectRxを中心とし、2020年5月に上場しました。
FICO vs SLQT — 直接比較
損益計算書 — Q1 FY2026 vs Q2 FY2026
| 指標 | ||
|---|---|---|
| 売上 | $512.0M | $537.1M |
| 純利益 | $158.4M | $69.3M |
| 粗利率 | 83.0% | 61.8% |
| 営業利益率 | 45.7% | 14.0% |
| 純利益率 | 30.9% | 12.9% |
| 売上前年比 | 16.4% | 11.6% |
| 純利益前年比 | 3.8% | 30.2% |
| EPS(希薄化後) | $6.61 | $0.26 |
緑 = その指標でリード。会計年度がずれている場合は期間が異なる場合あり
8四半期 売上・利益トレンド
並べて比較する四半期履歴。決算期がずれていても暦四半期で整列
| Q4 25 | $512.0M | $537.1M | ||
| Q3 25 | $515.8M | $328.8M | ||
| Q2 25 | $536.4M | $345.1M | ||
| Q1 25 | $498.7M | $408.2M | ||
| Q4 24 | $440.0M | $481.1M | ||
| Q3 24 | $453.8M | $292.3M | ||
| Q2 24 | $447.8M | $307.2M | ||
| Q1 24 | $433.8M | $376.4M |
| Q4 25 | $158.4M | $69.3M | ||
| Q3 25 | $155.0M | $-30.5M | ||
| Q2 25 | $181.8M | $12.9M | ||
| Q1 25 | $162.6M | $26.0M | ||
| Q4 24 | $152.5M | $53.2M | ||
| Q3 24 | $135.7M | $-44.5M | ||
| Q2 24 | $126.3M | $-31.0M | ||
| Q1 24 | $129.8M | $8.6M |
| Q4 25 | 83.0% | 61.8% | ||
| Q3 25 | 82.3% | 41.4% | ||
| Q2 25 | 83.7% | 47.2% | ||
| Q1 25 | 82.4% | 60.2% | ||
| Q4 24 | 80.1% | 67.5% | ||
| Q3 24 | 80.3% | 55.7% | ||
| Q2 24 | 80.3% | 60.7% | ||
| Q1 24 | 80.0% | 71.8% |
| Q4 25 | 45.7% | 14.0% | ||
| Q3 25 | 46.0% | -12.4% | ||
| Q2 25 | 48.9% | -3.6% | ||
| Q1 25 | 49.3% | 5.4% | ||
| Q4 24 | 40.8% | 14.7% | ||
| Q3 24 | 43.4% | -4.1% | ||
| Q2 24 | 42.5% | -0.5% | ||
| Q1 24 | 44.9% | 8.8% |
| Q4 25 | 30.9% | 12.9% | ||
| Q3 25 | 30.1% | -9.3% | ||
| Q2 25 | 33.9% | 3.7% | ||
| Q1 25 | 32.6% | 6.4% | ||
| Q4 24 | 34.7% | 11.1% | ||
| Q3 24 | 29.9% | -15.2% | ||
| Q2 24 | 28.2% | -10.1% | ||
| Q1 24 | 29.9% | 2.3% |
| Q4 25 | $6.61 | $0.26 | ||
| Q3 25 | $6.41 | $-0.26 | ||
| Q2 25 | $7.40 | $-0.06 | ||
| Q1 25 | $6.59 | $0.03 | ||
| Q4 24 | $6.14 | $0.30 | ||
| Q3 24 | $5.44 | $-0.26 | ||
| Q2 24 | $5.05 | $-0.17 | ||
| Q1 24 | $5.16 | $0.05 |
貸借対照表と財務力
直近四半期の流動性・レバレッジ・純資産のスナップショット
| 指標 | ||
|---|---|---|
| 現金・短期投資手元流動性 | $162.0M | $18.3M |
| 総負債低いほど良い | $3.2B | $405.8M |
| 株主資本純資産 | $-1.8B | $359.7M |
| 総資産 | $1.9B | $1.4B |
| 負債/資本比率低いほどレバレッジが低い | — | 1.13× |
8四半期トレンド — 暦四半期で整列
| Q4 25 | $162.0M | $18.3M | ||
| Q3 25 | $134.1M | $10.7M | ||
| Q2 25 | $189.0M | $32.4M | ||
| Q1 25 | $146.6M | $80.1M | ||
| Q4 24 | $184.3M | $7.3M | ||
| Q3 24 | $150.7M | $10.4M | ||
| Q2 24 | $156.0M | $42.7M | ||
| Q1 24 | $135.7M | $37.8M |
| Q4 25 | $3.2B | $405.8M | ||
| Q3 25 | $3.1B | $393.1M | ||
| Q2 25 | $2.8B | $385.1M | ||
| Q1 25 | $2.5B | $391.5M | ||
| Q4 24 | $2.4B | $711.9M | ||
| Q3 24 | $2.2B | $680.4M | ||
| Q2 24 | $2.1B | $683.3M | ||
| Q1 24 | $2.0B | $686.0M |
| Q4 25 | $-1.8B | $359.7M | ||
| Q3 25 | $-1.7B | $305.1M | ||
| Q2 25 | $-1.4B | $351.1M | ||
| Q1 25 | $-1.1B | $350.2M | ||
| Q4 24 | $-1.1B | $326.0M | ||
| Q3 24 | $-962.7M | $269.4M | ||
| Q2 24 | $-829.3M | $316.8M | ||
| Q1 24 | $-735.7M | $346.8M |
| Q4 25 | $1.9B | $1.4B | ||
| Q3 25 | $1.9B | $1.2B | ||
| Q2 25 | $1.9B | $1.2B | ||
| Q1 25 | $1.8B | $1.3B | ||
| Q4 24 | $1.7B | $1.3B | ||
| Q3 24 | $1.7B | $1.1B | ||
| Q2 24 | $1.7B | $1.2B | ||
| Q1 24 | $1.7B | $1.2B |
| Q4 25 | — | 1.13× | ||
| Q3 25 | — | 1.29× | ||
| Q2 25 | — | 1.10× | ||
| Q1 25 | — | 1.12× | ||
| Q4 24 | — | 2.18× | ||
| Q3 24 | — | 2.53× | ||
| Q2 24 | — | 2.16× | ||
| Q1 24 | — | 1.98× |
キャッシュフローと資本効率
再投資後に実際に生み出すキャッシュ。純利益より操作が難しい
| 指標 | ||
|---|---|---|
| 営業キャッシュフロー直近四半期 | $174.1M | $52.0K |
| フリーキャッシュフロー営業CF - 設備投資 | $173.9M | $-1.0M |
| FCFマージンFCF / 売上 | 34.0% | -0.2% |
| 設備投資強度設備投資 / 売上 | 0.0% | 0.2% |
| キャッシュ転換率営業CF / 純利益 | 1.10× | 0.00× |
| 直近12ヶ月FCF直近4四半期 | $750.6M | $8.5M |
8四半期トレンド — 暦四半期で整列
| Q4 25 | $174.1M | $52.0K | ||
| Q3 25 | $223.7M | $-21.6M | ||
| Q2 25 | $286.2M | $-37.5M | ||
| Q1 25 | $74.9M | $71.1M | ||
| Q4 24 | $194.0M | $-28.7M | ||
| Q3 24 | $226.5M | $-16.6M | ||
| Q2 24 | $213.3M | $20.0M | ||
| Q1 24 | $71.0M | $44.5M |
| Q4 25 | $173.9M | $-1.0M | ||
| Q3 25 | $219.5M | $-22.7M | ||
| Q2 25 | $284.4M | $-38.0M | ||
| Q1 25 | $72.8M | $70.2M | ||
| Q4 24 | $193.2M | $-29.0M | ||
| Q3 24 | $224.7M | $-17.1M | ||
| Q2 24 | $211.6M | $19.7M | ||
| Q1 24 | $67.0M | $43.4M |
| Q4 25 | 34.0% | -0.2% | ||
| Q3 25 | 42.6% | -6.9% | ||
| Q2 25 | 53.0% | -11.0% | ||
| Q1 25 | 14.6% | 17.2% | ||
| Q4 24 | 43.9% | -6.0% | ||
| Q3 24 | 49.5% | -5.8% | ||
| Q2 24 | 47.2% | 6.4% | ||
| Q1 24 | 15.4% | 11.5% |
| Q4 25 | 0.0% | 0.2% | ||
| Q3 25 | 0.8% | 0.3% | ||
| Q2 25 | 0.3% | 0.1% | ||
| Q1 25 | 0.4% | 0.2% | ||
| Q4 24 | 0.2% | 0.1% | ||
| Q3 24 | 0.4% | 0.2% | ||
| Q2 24 | 0.4% | 0.1% | ||
| Q1 24 | 0.9% | 0.3% |
| Q4 25 | 1.10× | 0.00× | ||
| Q3 25 | 1.44× | — | ||
| Q2 25 | 1.57× | -2.91× | ||
| Q1 25 | 0.46× | 2.73× | ||
| Q4 24 | 1.27× | -0.54× | ||
| Q3 24 | 1.67× | — | ||
| Q2 24 | 1.69× | — | ||
| Q1 24 | 0.55× | 5.20× |
財務フロー比較
売上 → 粗利 → 営業利益 → 純利益のサンキー図
セグメント別売上内訳
FICO
| Business To Business Scores | $248.6M | 49% |
| Saa S Products | $115.7M | 23% |
| Platform Software | $73.9M | 14% |
| Business To Consumer Scores | $55.9M | 11% |
| Technology Service | $19.2M | 4% |
SLQT
| Healthcare Services Segment | $230.7M | 43% |
| Pharmacy | $227.2M | 42% |
| Other | $30.4M | 6% |
| Final Expense | $20.4M | 4% |
| Term | $18.5M | 3% |
| Other Senior | $6.3M | 1% |
| All Other Revenue | $3.9M | 1% |